RNA Supply Chain Solutions

1. Vaccinia Capping System For mRNA Therapeutics 12/5/2025

   Backed by over a decade of expertise in capping enzyme production, this system is a robust, scalable solution designed to support production journeys from early R&D to full-scale manufacturing.

2. Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments 11/28/2023

   Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.

3. T Cell Kit For mRNA On NanoAssemblr Spark 4/14/2022

   The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.

4. Fit-For-Purpose And GMP Grade mRNA Reagents 3/24/2025

   Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.

5. mRNA Raw Materials: Supporting Your Journey To Market 12/5/2025

   Implementing a quality-by-design approach for manufacturing inputs limits contamination risks and simplifies regulatory compliance. Validated processes ensure consistency when scaling operations.

6. Mitigate Contamination Risks With HTST Flash Pasteurization 5/2/2024

   Gibco™ High-temperature, short-time (HTST) treatment of raw materials

   HTST treatment currently available in North America

   Simple sugar batch sizes ranging from 800 to 8,800 L

   In-house HTST preparation can be expensive and cumbersome. Outsourcing this technology to Thermo Fisher Scientific can alleviate production bottlenecks and increase viral mitigation confidence.

   Suitable and cost-effective for large volumes

   Standard and custom bioprocessing containers available (5 L–1,000 L). Please contact your sales representative.

7. High-Fidelity Nuclease For Therapeutic Breakthroughs 10/28/2024

   The hfCas12Max nuclease offers superior gene editing with high fidelity, broad PAM recognition, minimal off-target effects, and compatibility across cell types for therapeutic applications.

8. New Next-Generation GMP Facility 5/16/2023

   A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.

9. jetMESSENGER®: mRNA Transfection Reagent 3/21/2023

   Take your gene expression to the next level by switching to mRNA!

   Primary cells, neurons, suspension cells and various cancer cell lines are especially challenging to transfect. jetMESSENGER® gives high transfection efficiency in all of these usually difficult to transfect cells, by allowing highly efficient mRNA transfection.

   mRNA transfection is as easy as DNA transfection, with the advantage that mRNA does not need to reach the cell nucleus for expression nor require cell division for efficient gene expression. Hence, cells that are slow dividing or that have developed specific mechanisms to protect their genome can finally be used for gene expression.

   Unravel the full potential of your cells by switching to mRNA transfection.

10. Brochure: The Power Of Small: Nanoplasmid™ Vector Platform 1/19/2023

    With gene therapy advancing at a record pace, Aldevron recognizes the enormous promise your work can bring to therapeutics. We are proud to deliver a superior, modern plasmid technology to your therapeutic endeavors.